Close
Login to MyACC
ACC Members


Not a Member?

The Association of Corporate Counsel (ACC) is the world's largest organization serving the professional and business interests of attorneys who practice in the legal departments of corporations, associations, nonprofits and other private-sector organizations around the globe.

Join ACC

308 Results

Resource Listings

Articles
Checklists

Artificial Intelligence Toolkit for In-house Lawyers

By Association of Corporate Counsel

Gain insights on key topics around artificial intelligence. Learn tips on boosting your knowledge and use of generative AI, developing and implementing an AI governance strategy, integrating AI into the legal department, meeting ethical obligations, protecting your organization's intellectual property, and addressing AI issues in vendor contracts.

Articles

International Comparative Legal Guide to Technology Sourcing 2024

By Global Legal Group

This resource provides jurisdiction-by-jurisdiction guidance to technology sourcing laws and regulations around the world.

This guide covers issues relating to procurement processes, dispute resolution procedures, intellectual property rights, data protection and employment law.

Articles

The Tax Man Cometh: Tax Perils in Physician Recapitalization Transactions

By Roger D. Strode Steven M. Gerenraich Timothy L. Voigtman

This blog explores physician recapitalization transactions and how complex they are and their myriad issues. At Foley, in our representation of both investors in, and sellers of, physician practices, we note how often tax issues become gating items that drive the structural aspects of the transaction.

Articles

The 340B Drug Pricing Program: Key Thing to Know

By Adria Warren, Partner, Foley & Lardner LLP, Anil Shankar, Partner, Foley & Lardner LLP, and Madeline Knight, Associate, Foley & Lardner LLP

Since its inception in 1992, the 340B Drug Pricing Program (340B Program) has provided eligible health care providers (covered entities) access to significant discounts on the cost of outpatient pharmaceuticals from participating manufacturers.

Over the past 15 years, the 340B Program’s size and scope has expanded due to actions by Congress and the federal Health Resources and Services Administration (HRSA). This article provides an overview of the program's current state.